|Articles|October 10, 2022
Q² Solutions Launches Self-Collection Safety Lab Panel in Collaboration With Tasso
New offering combines laboratory services, patient-focused logistics, and self-collection technology.
Advertisement
Q² Solutions has announced the launch of a self-collection safety lab panel for US clinical trial participants. Developed in collaboration with Tasso, this offering combines laboratory services, patient focused logistics, and self-collection technology.
Read more about the new offering
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
2
Streamlining Clinical Data to Reduce Site and Participant Burden
3
Utilizing Tech Tools to Accelerate Drug Development
4
ACT Brief: Lilly Seeks FDA Priority Review for Oral GLP-1 as Bispecific Antibody Trials Redefine Ethical Standards
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
